| scholarly article | Q13442814 |
| P50 | author | Ivana Carey | Q57063795 |
| P2093 | author name string | Giorgina Mieli-Vergani | |
| Sanjay Bansal | |||
| Yun Ma | |||
| Diego Vergani | |||
| Irene Rebollo Mesa | |||
| Maria Serena Longhi | |||
| Lorenzo D'Antiga | |||
| P2860 | cites work | Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity | Q75349177 |
| Immunological techniques in viral hepatitis | Q79614664 | ||
| Hepatitis B virus infection--natural history and clinical consequences | Q29617961 | ||
| Immunology of hepatitis B virus and hepatitis C virus infection | Q29618957 | ||
| Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy | Q34151071 | ||
| A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples | Q34721532 | ||
| Immunopathogenesis of hepatitis B. | Q35621639 | ||
| Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection | Q35763331 | ||
| The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection | Q36368397 | ||
| Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. | Q36382269 | ||
| Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection | Q37353679 | ||
| Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. | Q37384895 | ||
| Hepatitis B virus resistance to nucleos(t)ide analogues. | Q37593697 | ||
| HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen | Q37627780 | ||
| Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy | Q39376578 | ||
| Sequence variation of hepatitis B virus precore-core open reading frame isolated from serum and liver of children with chronic hepatitis B before and after interferon treatment | Q42476202 | ||
| Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa | Q43279592 | ||
| Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. | Q43563104 | ||
| Real-time PCR for detection and quantitation of hepatitis B virus DNA. | Q43728363 | ||
| Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus | Q44444926 | ||
| Antiviral T-cell responses and therapy in chronic hepatitis B. | Q44583432 | ||
| Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. | Q44929883 | ||
| Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-alpha | Q45002710 | ||
| Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission | Q45183116 | ||
| Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance? | Q45273524 | ||
| Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants | Q45565589 | ||
| T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection | Q45739577 | ||
| Long-term follow-up study of core gene deletion mutants in children with chronic hepatitis B virus infection. | Q45741840 | ||
| Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis | Q45763494 | ||
| Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection | Q45766634 | ||
| The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. | Q45767731 | ||
| Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus | Q45788871 | ||
| Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity | Q46775423 | ||
| Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study | Q46955729 | ||
| Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B. | Q51907463 | ||
| A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. | Q53868287 | ||
| Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment. | Q54180821 | ||
| Viral Quasi-Species Evolution During Hepatitis Be Antigen Seroconversion | Q58002623 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| hepatitis B | Q6853 | ||
| P304 | page(s) | 2416-2428 | |
| P577 | publication date | 2010-12-08 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy | |
| P478 | volume | 85 |
| Q58555270 | A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion |
| Q38258081 | Age-Dependent Immune Events during HBV Infection from Birth to Adulthood: An Alternative Interpretation |
| Q36101272 | Altered Immune Profiles of Natural Killer Cells in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis |
| Q40139678 | Analysis of immunological mechanisms exerted by HBsAg-HBIG therapeutic vaccine combined with Adefovir in chronic hepatitis B patients |
| Q38232829 | Chronic hepatitis B virus in young adults: the need for new approaches to management |
| Q33578026 | Cimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell |
| Q43466658 | Cure for immune-tolerant hepatitis B in children: is it an achievable target with sequential combo therapy with lamivudine and interferon? |
| Q59359697 | Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand |
| Q35111394 | Defective natural killer cell anti-viral capacity in paediatric HBV infection |
| Q98892449 | Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients |
| Q41718138 | HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy |
| Q28066219 | Hepatitis B Management in the Pregnant Patient: An Update |
| Q41982541 | Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection |
| Q37296897 | Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children |
| Q45340695 | Hepatitis B virus in children: More therapeutic options-but unknown and known unknowns still present |
| Q55254424 | Immune Ecosystem of Virus-Infected Host Tissues. |
| Q38733622 | Immune balance in Hepatitis B Infection: Present and Future Therapies |
| Q35691243 | Immune tolerant hepatitis B: a clinical dilemma. |
| Q36073739 | Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections |
| Q47556416 | Immunotherapy for Chronic Hepatitis B Virus Infection |
| Q37402451 | Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice |
| Q27678163 | The L60V Variation in Hepatitis B Virus Core Protein Elicits New Epitope-Specific Cytotoxic T Lymphocytes and Enhances Viral Replication |
| Q38245181 | The immune tolerant phase of chronic HBV infection: new perspectives on an old concept |
| Q33563893 | To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy |
| Q39419957 | Tolerance and immunity to pathogens in early life: insights from HBV infection. |
Search more.